[1] AWMF (Deutsche Gesellschaft für Pneumologie und Beatmungsmedizin e.V. [DGP], Deutsche Gesellschaft für Allgemein- und Viszeralchirurgie e.V. [DGAV]). S2k-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von erwachsenen Patienten mit Husten. Stand 01.01.2019. AWMF-Register-Nr.: 020-003. Verfügbar online unter https://www.awmf.org/uploads/tx_szleitlinien/020-003l_S2k_Diagnostik-Therapie-erwachsene-Patienten-mit-Husten_2019-12.pdf [eingesehen am 02.11.2022].
[2] Sun H, Kollarik M, Undem BJ. Blocking voltage-gated sodium channels as a strategy to suppress pathological cough. Pulm Pharmacol Ther 2017;47:38-41.
[3] Canning BJ. Functional implications of the multiple afferent pathways regulating cough. Pulm Pharmacol Ther 2011;24:295-299.
[4] Mazzone SB, Undem BJ. Vagal Afferent innervation of the airways in health and disease. Physiol Rev 2016;96:975-1024.
[5] West PW, Canning BJ, Merlo-Pich E, Woodcock AA, Smith JA. Morphologic Characterization of Nerves in Whole-Mount Airway Biopsies. Am J Resp Crit Care Med 2015;192(1):30-39.
[6] Mazzone SB, Chung KF, McGarvey L. The heterogenecity of chronic cough: a case for the endotypes of cough hypersensitivity. Lancet Respir Med 2018;6(8):636-646.
[7] Bonvini SJ, Belvisi MG. Cough and airway disease: the role of ion channels. Pulm Pharmacol Ther 2017;47:21-28.
[8] Birrell MA, Belvisi MG, Grace M, et al. TRPA1 agonists evoke coughing in guinea pig and human volunteers. Am J Respir Crit Care Med 2009;180(11):1042-1047.
[9] Belvisi MG, Birrell MA. The emerging role of transient receptor potential channels in chronic lung disease. Eur Respir J 2017;50(2):1601357.
[10] Li M, Wang Y, Banerjee R, et al. Molecular mechanisms of human P2X3 receptor channel activation and modulation by divalent cation bound ATP. Elife. 2019;8:e47060.
[11] Morice AH, Millqvist E, Bieksiene K, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J 2020;55(1):1901136 [https://doi.org/10.1183/ 13993003.01136-2019].
[12] Canning BJ, Chang AB, Bolser DC, et al on behalf of the CHEST Expert Cough Panel. Anatomy and Neuro-physiology of Cough. CHEST Guideline and Expert Panel Report. CHEST 2014;146(6):1633-1648.
[13] Smith JA, Badri H. Cough: new pharmacology. J Allergy Clin Immunol Pract.2019;7(6):1731-1738.
Literaturhinweise Abbildung 1:
a. Mazzone SB, Undem BJ. Vagal afferent innervation of the airways in health and disease. Physiol Rev 2016;96(3):975-1024.
b. Mazzone SB, McGarvey L. Mechanisms and rationale for targeted therapies in refractory and unexplained chronic cough [published online ahead of print, 2020 Aug 4]. Clin Pharmacol Ther 2020;10.1002/cpt.2003.
c. Gibson P, Wang G, McGarvey L, et al. Treatment of unexplained chronic cough: CHEST Guideline and Expert Panel Report. Chest. 2016;149(1):27-44.
d. Mazzone SB, Chung KF, McGarvey L. The heterogeneity of chronic cough: a case for endotypes of cough hy-persensitivity. Lancet Respir Med 2018;6(8):636-646.
e. Bonvini SJ, Belvisi MG. Cough and airway disease: the role of ion channels. Pulm Pharmacol Ther 2017;47:21-28.
f. West PW, Canning BJ, Merlo-Pich E, Woodcock AA, Smith JA. Morphologic characterization of nerves in whole-mount airway biopsies. Am J Respir Crit Care Med. 2015;192(1):30-39.
g. Smith JA, Badri H. Cough: new pharmacology. J Allergy Clin Immunol Pract 2019;7(6):1731-1738.
h. Canning BJ, Chang AB, Bolser DC, Smith JA, Mazzone SB, McGarvey L. CHEST Expert Cough Panel. Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel Report. Chest 2014;146(6):1633-1648.
